<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="39112">Bosutinib</z:chebi> (Bosulif) tablets for <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo>; linaclotide (Linzess) for <z:e sem="disease" ids="C0022104" disease_type="Disease or Syndrome" abbrv="IBS">irritable bowel syndrome</z:e>/<z:hpo ids='HP_0002019'>constipation</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> idiopathic <z:hpo ids='HP_0002019'>constipation</z:hpo>; and regorefenib (Stivarga) tablets for <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> </plain></SENT>
</text></document>